Finance

It doesn’t need to do anything differently to keep succeeding.

With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21.

Want Social Security to provide the maximum amount of retirement income? Employ these four strategies.

Your retirement income action plan is here.

Only one of them is moving higher on Friday, though.

An FDA advisory committee made it clear that they don’t want the agency to approve roxadustat due to safety concerns.

The e-commerce giant is riding a wave of robust revenue and profit gains.

The meme stock movement is all but finished, pulling the rug out from underneath all the names swept up in the mania.

The telecommunications equipment provider reports disappointing second-quarter results.

Find out why a big index move is so interesting for investors.

The space story pivoted from Virgin Galactic to Blue Origin this week.

The company will be issuing stock to redeem its public warrants.

One analyst sees significant upside for this top producer of DRAM memory products.

Electric-powered coupes and sedans aren’t the only sets of wheels that investors are charged up about.

Investors appear to be reacting to a rival’s recent acquisition.

Peloton is more than just an iPad-on-a-bike company.

The copper producer is facing some headwinds.

Square’s a Bitcoin fan, but criticism from Dogecoin’s creator still stings.

After rallying on the coattails of Intelllia’s breakthrough, these companies have given back their June gains.

Management has good reasons to upgrade its 2021 growth outlook after releasing its second-quarter results.